(Q45669616)

English

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

scientific article published in March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

based on heuristic

inferred from title

4

object named as

Pierre Pothier

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Béatrice Nicollier-Jamot

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Agathe Ogier

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Lionel Piroth

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Evelyne Kohli

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

9-10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1079-1086

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Virus taxonomy - Houston 2002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Human caliciviruses in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Virus diversity in a winter epidemic of acute diarrhea in France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Immunity to calicivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-like particle vaccines for mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.10.004

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45669616&oldid=2077461988"